The Oncology Information System Market Size was valued at USD 3.36 billion in 2023, and is expected to reach USD 6.13 billion by 2031, and grow at a CAGR of 7.8% over the forecast period 2024-2031.
Oncology Information System (OIS) is a piece of software used to manage and store patient profiles in health care facilities like clinics, hospitals, and research labs. Its objectives include enhancing efficiency, connecting various oncology skills, and ensuring the efficient use of resources to facilitate the smooth running of the oncology institute. This software provides a tool to track the profiles of a cancer patient, which is why it improves the efficiency and safety of patients. It is staffed in Medical Oncology, Surgical Oncology, and Radiation Oncology, among other things.
Get more information on Oncology Information System Market - Request Sample Report
Treatment delivery, Treatment plans, treatment summaries, patient treatment schedules, and results will all need to be managed through a system. The data presented above is managed using an oncology information system (OIS). The system connects radiation treatment departments with the rest of the healthcare system.
DRIVERS
Costs of cancer care must be reduced.
EHRs and other oncology healthcare IT solutions are becoming more widely used, which is helping to improve patient care.
Cancer is becoming more common and is becoming more prevalent.
Government mandates that favour oncology information systems and support for them
Oncology information systems have the potential to aid patients and have advanced technologically.
RESTRAINTS
Issues concerning interoperability
In the healthcare industry, there is a scarcity of skilled IT personnel
OPPORTUNITIES
The healthcare information technology industry is expanding.
Integration of electronic medical records with treatment planning systems
CHALLENGES
Concerns about data security
The emergence of COVID-19 has a profound impact on the field of oncology information systems. Government restrictions on closures and social reduction measures to combat the COVID-19 epidemic have led to the suspension of various activities, hampering business growth, cancellation of technical events, disruption of supply chain, and suspension of new development, all of which have had implications. in the production and sale of the whole, which limits the expansion of the industry. As a result of the suspension, the construction and delivery of essential health care items has had an impact on both. During the outbreak, many hospitals and cancer clinics were closed, reducing the need for OIS solutions. In addition, hospitals are increasingly focused on the management of COVID-19 patients, limiting their ability to market and deploy cancer information systems.
The demand for cancer information systems has declined as a result of the epidemic, as doctors were treating more COVID-19 patients than normal patients. On the other side, an increase in vaccination rates will help to keep the market stable. As a result, the market is expected to grow rapidly following COVID, as all of the previously delayed and postponed treatments will resume once the number of COVID cases decreases.
By Product & Service Type
Software and professional services have been separated from the market. Patient information systems and treatment planning systems are two types of software in the software category. Consulting/optimization services, implementation services, and post-sale & maintenance services are all included in the professional services category. When compared to traditional record maintenance methods, the software for patient information systems sector led the market in 2017. These systems provide benefits such as scheduled treatment and distant access due to digital availability.
By Application
Medical oncology, radiation oncology, and surgical oncology are the three segments of the market. Due to increased applications of OIS in efficiently managing, interpreting, analysing, and preserving patient information, as well as in predicting treatment results for patients, the medical oncology segment is expected to lead the market over the estimate period.
By End User
Hospitals and diagnostic centers, cancer care centers, government agencies, and research centers are all included. The active field of cancer information market was full of hospitals and diagnostic centers. The proliferation of government programs aimed at equipping (or improving) hospitals with new and improved programs, as well as the large amount of information generated during cancer screening and treatment and the significant number of annual patient visits around the world, are some of the driving factors. the growth of this phase.
By Product & Service Type
Software
Patient Information Systems
Treatment Planning Systems
Professional Services
Consulting/Optimization Services
Implementation Services
Post-sale & Maintenance Services
By Application
Medical Oncology
Radiation Oncology
Surgical Oncology
By End User
Hospitals & Oncology Clinics
Government Institutes
Research Centers
.png)
Need any customization research on Oncology Information System Market - Enquiry Now
The highest revenue share came from the North American regional market. The presence of advanced healthcare infrastructure and increased awareness about patient information management in the region are two key elements driving this expansion. Furthermore, the expanding importance of EMR for making better treatment decisions and the growing implementation of OIS to follow and record treatment results of cancer patients are likely to promote regional market growth. The need for OIS in this region is likely to rise as the necessity for treatment schedule management, dosage control, and treatment planning grows.
Asian countries, on the other hand, have a strong demand for OIS and are gradually developing as a result of favourable government policies and increased understanding of the systems' benefits. This location could be a lucrative money source for players that want to take advantage of its possibilities. As a result, firms seeking a substantial portion of this market must adopt specific pricing policies as well as marketing tactics tailored to this region in order to gain a foothold in these profitable markets.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players of the Oncology Information System Market are as follows: Elekta AB, Accuray Inc., BrainLab, Cerner Corp., DOSIsoft S.A., Philips Healthcare, RaySearch Laboratories, Prowess, Inc., Varian Medical Systems, ViewRay Inc., Flatiron and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 3.36 Billion |
| Market Size by 2031 | US$ 6.13 Billion |
| CAGR | CAGR of 7.8% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product & Service Type (Software (Patient Information Systems, Treatment Planning Systems), Professional Services (Consulting/Optimization Services, Implementation Services, Post-sale & Maintenance Services) • By Application (Medical Oncology, Radiation Oncology, Surgical Oncology) • By End User (Hospitals & Oncology Clinics, Government Institutes, Research Centers) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Elekta AB, Accuray Inc., BrainLab, Cerner Corp., DOSIsoft S.A., Philips Healthcare, RaySearch Laboratories, Prowess, Inc., Varian Medical Systems, ViewRay Inc., Flatiron. |
| DRIVERS | • Costs of cancer care must be reduced. • EHRs and other oncology healthcare IT solutions are becoming more widely used, which is helping to improve patient care. • Cancer is becoming more common and is becoming more prevalent. |
| RESTRAINTS | • Issues concerning interoperability • In the healthcare industry, there is a scarcity of skilled IT personnel. |
Ans: The Oncology Information System market is to grow at a CAGR of 7.6% over the forecast period 2023-2030.
Drivers, Restraints, Opportunities, and Challenges are the factors of marketing dynamics Population Health Management market.
Hospitals & Oncology Clinics, Government Institutes, and Research Centers are the sub segments of end use of Oncology Information System market.
Yes, this report covers qualitative and quantitative analysis.
Ans: The Oncology Information System Market size was valued at US$ 5.60 billion by 2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Oncology Information System Market Segmentation, By Product & Service Type
8.1 Software
8.1.1 Patient Information Systems
8.1.2 Treatment Planning Systems
8.2 Professional Services
8.2.1 Consulting/Optimization Services
8.2.2 Implementation Services
8.2.3 Post-sale & Maintenance Services
9. Oncology Information System Market Segmentation, By Application
9.1 Medical Oncology
9.2 Radiation Oncology
9.3 Surgical Oncology
10. Oncology Information System Market Segmentation, By End User
10.1 Hospitals & Oncology Clinics
10.2 Government Institutes
10.3 Research Centers
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 Elekta AB
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Accuray Inc.
12.3 BrainLab, Cerner Corp.
12.4 DOSIsoft S.A.
12.5 Philips Healthcare
12.6 RaySearch Laboratories
12.7 Prowess, Inc.
12.8 Varian Medical Systems
12.9 ViewRay Inc.
12.10 Flatiron
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The global pharmaceutical logistics market, valued at USD 92.20 Billion in 2023, is projected to reach USD 201.99 Billion by 2032, growing at a compound annual growth rate CAGR of 9.59% during the forecast period.
The Global Vaccine Market Size valued at USD 74.7 billion in 2023, projected to reach USD 186.5 billion by 2032, with a CAGR of 10.7%.
The Respiratory Devices Market was valued at USD 22.62 billion in 2023 and is projected to reach USD 46.10 billion by 2032, growing at a robust CAGR of 8.27 % during the forecast period of 2024-2032.
The Angioplasty Balloon Market size was estimated at USD 3.05 billion in 2023 and will hit USD 4.18 billion by 2031 growing at a CAGR of 4.01% by 2024-2031.
The Molecular Quality Controls Market size was estimated at USD 0.1 billion in 2023 and is expected to reach USD 0.16 billion by 2031 with a growing CAGR of 6.7% during the forecast period of 2024-2031.
The Health Insurance Exchange Market Size was valued at USD 2553.96 Billion in 2023 and is expected to reach USD 5,751.80 Billion by 2032 and grow at a CAGR of 9.91% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
